- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Clinical and Developmental Immunology
Volume 2012 (2012), Article ID 206730, 6 pages
Family History of Autoimmune Disease in Patients with Aicardi-Goutières Syndrome
1Department of Neurology, Children's National Medical Center, Washington, DC 20010, USA
2Center for Genetic Medicine Research, Children's National Medical Center, Washington, DC 20010, USA
3Unit of Child Neurology and Psychiatry, C. Mondino National Institute of Neurology Foundation, Pavia 27100, Italy
4Department of Child and Adolescent Neuropsychiatry, University of Brescia, Brescia 25123, Italy
Received 17 June 2012; Accepted 1 October 2012
Academic Editor: Timothy B. Niewold
Copyright © 2012 Johanna L. Schmidt et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- Y. J. Crow and J. H. Livingston, “Aicardi-Goutières syndrome: an important Mendelian mimic of congenital infection,” Developmental Medicine and Child Neurology, vol. 50, no. 6, pp. 410–416, 2008.
- P. Lebon, J. Badoual, G. Ponsot, F. Goutieres, F. Hemeury-Cukier, and J. Aicardi, “Intrathecal synthesis of interferon-α in infants with progressive familial encephalopathy,” Journal of the Neurological Sciences, vol. 84, no. 2-3, pp. 201–208, 1988.
- N. Blau, L. Bonafé, I. Krägeloh-Mann et al., “Cerebrospinal fluid pterins and folates in Aicardi-Goutières syndrome: a new phenotype,” Neurology, vol. 61, no. 5, pp. 642–647, 2003.
- E. Wassmer, J. Singh, S. Agrawal, S. Santra, and Y. J. Crow, “Elevated pterins in cerebral spinal fluid—biochemical marker of Aicardi-Goutières syndrome,” Developmental Medicine and Child Neurology, vol. 51, no. 10, pp. 841–842, 2009.
- J. Aicardi and F. Goutieres, “Systemic lupus erythematosus or Aicardi-Goutières syndrome?” Neuropediatrics, vol. 31, no. 3, article 113, 2000.
- Y. J. Crow, D. N. Black, M. Ali et al., “Cree encephalitis is allelic with aicardi-goutières syndrome: implications for the pathogenesis of disorders of interferon α metabolism,” Journal of Medical Genetics, vol. 40, no. 3, pp. 183–187, 2003.
- C. de Laet, P. Goyens, C. Christophe, A. Ferster, F. Mascart, and B. Dan, “Phenotypic overlap between infantile systemic lupus erythematosus and Aicardi-Goutières syndrome,” Neuropediatrics, vol. 36, no. 6, pp. 399–402, 2005.
- R. C. Dale, S. Ping Tang, J. Z. Heckmatt, and F. M. Tatnall, “Familial systemic lupus erythematosus and congenital infection-like syndrome,” Neuropediatrics, vol. 31, no. 3, pp. 155–158, 2000.
- M. A. Lee-Kirsch, M. Gong, D. Chowdhury et al., “Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 are associated with systemic lupus erythematosus,” Nature Genetics, vol. 39, no. 9, pp. 1065–1067, 2007.
- B. Namjou, P. H. Kothari, J. A. Kelly et al., “Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort,” Genes and Immunity, vol. 12, no. 4, pp. 270–279, 2011.
- C. Günther, M. Meurer, A. Stein, A. Viehweg, and M. A. Lee-Kirsch, “Familial chilblain lupus—a monogenic form of cutaneous lupus erythematosus due to a heterozygous mutation in TREX1,” Dermatology, vol. 219, no. 2, pp. 162–166, 2009.
- G. Rice, W. G. Newman, J. Dean et al., “Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi-Goutières syndrome,” American Journal of Human Genetics, vol. 80, no. 4, pp. 811–815, 2007.
- J. C. Ravenscroft, M. Suri, G. I. Rice, M. Szynkiewicz, and Y. J. Crow, “Autosomal dominant inheritance of a heterozygous mutation in SAMHD1 causing familial chilblain lupus,” American Journal of Medical Genetics A, vol. 155, no. 1, pp. 235–237, 2011.
- A. Richards, A. M. J. M. van den Maagdenberg, J. C. Jen et al., “C-terminal truncations in human 3′-5′ DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy,” Nature Genetics, vol. 39, no. 9, pp. 1068–1070, 2007.
- D. C. Goldstone, V. Ennis-Adeniran, J. J. Hedden, et al., “HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase,” Nature, vol. 480, no. 7377, pp. 379–382, 2011.
- G. I. Rice, J. Bond, A. Asipu, et al., “Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune response,” Nature Genetics, vol. 41, no. 7, pp. 829–832, 2009.
- D. B. Stetson, J. S. Ko, T. Heidmann, and R. Medzhitov, “Trex1 prevents cell-intrinsic initiation of autoimmunity,” Cell, vol. 134, no. 4, pp. 587–598, 2008.
- D. L. Jacobson, S. J. Gangea, N. R. Roseb, and N. M.H. Graham, “Epidemiology and estimated population burden of selected autoimmune diseases in the United States,” Clinical Immunology and Immunopathology, vol. 84, no. 3, pp. 223–243, 1997.
- J. C. Prinz, “The role of T cells in psoriasis,” Journal of the European Academy of Dermatology and Venereology, vol. 17, no. 3, pp. 257–270, 2003.
- J. C. Diniz, R. T. Almeida, N. E. Aikawa, A. Sallum, P. T. Sakane, and C. A. Silva, “Kawasaki disease and juvenile systemic lupus erythematosus,” Lupus, vol. 21, no. 1, pp. 89–92, 2012.
- Y. J. Crow, “Type I interferonopathies: a novel set of inborn errors of immunity,” Annals of the New York Academy of Sciences, vol. 1238, no. 1, pp. 91–98, 2011.
- T. B. Niewold, J. Hua, T. J. A. Lehman, J. B. Harley, and M. K. Crow, “High serum IFN-α activity is a heritable risk factor for systemic lupus erythematosus,” Genes and Immunity, vol. 8, no. 6, pp. 492–502, 2007.
- T. B. Niewold, S. C. Wu, M. Smith, G. A. Morgan, and L. M. Pachman, “Familial aggregation of autoimmune disease in juvenile dermatomyositis,” Pediatrics, vol. 127, no. 5, pp. e1239–e1246, 2011.